Welcome to our dedicated page for Bioceres Crop Solutions SEC filings (Ticker: BIOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bioceres Crop Solutions Corp. (NASDAQ: BIOX) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer. Bioceres files annual reports on Form 20-F and frequent current reports on Form 6-K, presenting financial statements in accordance with International Financial Reporting Standards (IFRS) and expressing figures in U.S. dollars.
Through these filings, readers can review segment-level financial information for Bioceres’ Crop Protection, Seed and Integrated Products, and Crop Nutrition businesses, along with consolidated statements of comprehensive income, financial position and cash flows. The documents also discuss non-IFRS measures such as Adjusted EBITDA and provide reconciliations and explanations referenced in the company’s earnings releases.
Bioceres’ Form 6-K submissions include earnings press releases for quarterly and full-year periods, subsidiary financial statements, and materials for its Annual General Meeting, such as notices and proxy documents. Other 6-Ks describe governance and management changes, including appointments and resignations of directors and executives, and the designation of a principal accounting officer.
The filings also detail financing arrangements and legal matters, such as secured and convertible note purchase agreements, corporate bonds and amendments to these instruments. In a November 2025 Form 6-K, Bioceres reported receiving a Declaration of Acceleration of Notes from certain noteholders and disclosed related litigation, while stating that it disputes the alleged defaults and intends to defend its position.
On Stock Titan, these SEC filings are updated as they are released on EDGAR, and AI-powered tools can be used to summarize lengthy documents, highlight key segment data, and help readers quickly locate information on topics such as revenue composition, debt instruments, equity structure and governance disclosures.
Bioceres Crop Solutions Corp. reported that a UCC foreclosure sale was held on January 20, 2026 on collateral pledged by Pro Farm Group, Inc. and Pro Farm Michigan Manufacturing, LLC under notes issued in August 2022 and amended in June 2025. The only qualified bid came from PFG Holdings Corp, a joint venture formed by the noteholders, which made a credit bid of $15 million in notes and was declared the winning bidder.
The sale was conducted virtually with representatives of the company, the noteholders, and their respective counsel present. Bioceres states that it disputes the alleged defaults that led to the foreclosure and the commercial reasonableness of the sale, and it reserves all rights and remedies.
Bioceres Crop Solutions Corp. submitted a Form 6-K as a foreign private issuer for November 2025. The filing mainly serves as a cover document for unaudited interim condensed consolidated financial statements as of September 30, 2025 and June 30, 2025, and for the three-month periods ended September 30, 2025 and 2024, which are included as Exhibit 99.1. The Form 6-K also states that this information is incorporated by reference into the company’s existing registration statements on Form F-3 and multiple Form S-8 registrations.
Bioceres Crop Solutions (BIOX) reported that noteholders delivered a Declaration of Acceleration on its convertible and non-convertible notes on November 10, 2025, alleging uncured defaults. On November 11, 2025, these holders filed a lawsuit in New York Supreme Court seeking payment in full under the note agreements.
The company disputes the allegations and the purported effect of the acceleration and says it will vigorously defend its position. The filing also notes that this 6-K is incorporated by reference into existing Form F-3 and S-8 registration statements.
Bioceres Crop Solutions (BIOX) filed its annual report (Form 20-F) for the year ended June 30, 2025. The company highlights a reshaped debt profile and liquidity pressures following note amendments and covenant breaches.
Convertible Notes total $67,868,227 at 15% interest (5% cash, 10% paid in kind) with maturity extended to August 31, 2027. Non-Convertible Notes total $29,081,233 at 19% interest (14% cash, 5% paid in kind) with monthly amortization. Due to covenant breaches as of June 30, 2025, $102.3 million of notes were reclassified as current liabilities. Total indebtedness was $260.2 million, with $222.0 million maturing in the fiscal year ending June 30, 2026. Management’s financial statements include a statement of substantial doubt about the company’s ability to continue as a going concern.
The report also notes a change-of-control event at Bioceres Group Limited on June 16, 2025, creating termination rights under the HB4 licensing agreement. BIOX transitioned HB4 from direct seed sales to a licensing model. 63,228,239 ordinary shares were outstanding as of June 30, 2025.
Bioceres Crop Solutions Corp. (BIOX) reported leadership changes. Effective November 5, 2025, the Board appointed Simon Vumbaca as a director. The company describes him as a multi‑jurisdictional lawyer focused on cross‑border structuring, geopolitical strategy, and crisis arbitration, who advises sovereigns, ultra‑high‑net‑worth families, and global enterprises; he chairs AIG’s Board and serves as a non‑executive director of Elemental Altus.
Also effective November 5, 2025, the Board named Alejandro Villafane as Principal Accounting Officer, formalizing oversight for the company’s accounting function.
Bioceres Crop Solutions Corp. reported a governance change, noting that board member Scott Crocco resigned from the company’s board of directors effective October 10, 2025. The filing states only the fact and effective date of his departure, without describing any related circumstances or strategic changes. The report is also designated to be incorporated by reference into the company’s existing Form F-3 and Form S-8 registration statements.
Bioceres Crop Solutions Corp. reports that Noah Kolatch resigned from its board of directors effective September 30, 2025. His resignation is linked to a reservation of rights letter sent to the company by Jasper Lake through counsel on September 25, 2025, which raised issues under existing Note Purchase Agreements. The company responded on September 30, 2025 with its own reservation of rights letter, disputing that any Events of Default have occurred and expressing its view that constructive dialogue with Jasper Lake is in the best interests of the company and its stakeholders. Bioceres states that it remains focused on improving its commercial and financial performance and on delivering innovative agricultural solutions.
Bioceres Crop Solutions Corp. received an Amendment No. 1 to a Schedule 13D filed by Jasper Lake Ventures One LLC and Noah Kolatch reporting a combined beneficial position of 7,482,961 ordinary shares, representing approximately 10.7% of outstanding shares on a diluted basis. The reported amount includes 397,000 shares held directly and 7,085,961 shares issuable upon conversion of notes convertible within 60 days. Jasper Lake notified the issuer on September 25, 2025 that it believes certain Events of Default under a Note Purchase Agreement have occurred and reserved all rights; the issuer disputes that claim. In connection with this dispute, Mr. Kolatch resigned from the issuer's board effective September 30, 2025. The filing otherwise restates ownership, voting/dispositive powers (shared) and confirms no transactions in the prior 60 days.